EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement

Cristina Popescu, Constantin Munteanu iD, Aurelian Anghelescu iD, Vlad Ciobanu, Aura Spînu, Ioana Andone, Mihaela Mandu, Roxana Bistriceanu, Mihai Băilă, Ruxandra-Luciana Postoiu, Andreea-Iulia Vlădulescu-Trandafir iD, Sebastian Giuvara und 2 weitere

International Journal of Molecular Sciences · 19.10.2024 · 25 (20) · 11272

DOI: 10.3390/ijms252011272 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.10.2024. Verfasst von Cristina Popescu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Medicine and Pharmacy "Carol Davila", 020022 Bucharest, Romania. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome, Mouth, Neuroinflammatory Diseases. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Publication of this paper was supported by the University of Medicine and Pharmacy "Carol Davila" through the institutional program Publish not Perish", “Publication of this paper was supported by the University of Medicine and Pharmacy “Carol Davila” through the institutional program Publish not Perish”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies underscore the role of gut and oral microbiota in influencing neuroinflammation through the microbiota–gut–brain axis, including in Alzheimer’s disease (AD). This review aims to provide a comprehensive synthesis of recent findings on the involvement of gut and oral microbiota in the neuroinflammatory processes associated with AD, emphasizing novel insights and therapeutic implications. This review reveals that dysbiosis in AD patients’ gut and oral microbiota is linked to heightened peripheral and central inflammatory responses. Specific bacterial taxa, such as Bacteroides and Firmicutes in the gut, as well as Porphyromonas gingivalis in the oral cavity, are notably altered in AD, leading to significant changes in microglial activation and cytokine production. Gut microbiota alterations are associated with increased intestinal permeability, facilitating the translocation of endotoxins like lipopolysaccharides (LPS) into the bloodstream and exacerbating neuroinflammation by activating the brain’s toll-like receptor 4 (TLR4) pathways. Furthermore, microbiota-derived metabolites, including short-chain fatty acids (SCFAs) and amyloid peptides, can cross the blood-brain barrier and modulate neuroinflammatory responses. While microbial amyloids may contribute to amyloid-beta aggregation in the brain, certain SCFAs like butyrate exhibit anti-inflammatory properties, suggesting a potential therapeutic avenue to mitigate neuroinflammation. This review not only highlights the critical role of microbiota in AD pathology but also offers a ray of hope by suggesting that modulating gut and oral microbiota could represent a novel therapeutic strategy for reducing neuroinflammation and slowing disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGastrointestinal MicrobiomeMouthNeuroinflammatory DiseasesDysbiosisHumansAnimalsBrain-Gut Axis

Stichwörter der Autor:innen

Alzheimer’s disease (AD)amyloid peptidesdysbiosisgut microbiotaneuroinflammation

Autor:innen und Institutionen

  • Faculty of Medicine, University of Medicine and Pharmacy "Carol Davila", 020022 Bucharest, Romania.
  • Neuromuscular Rehabilitation Clinic Division, Clinical Emergency Hospital "Bagdasar-Arseni", 041915 Bucharest, Romania.
  • Department of Biomedical Sciences, Faculty of Medical Bioengineering, University of Medicine and Pharmacy "Grigore T. Popa" Iași, 700454 Iași, Romania.
  • Department of Computer Science and Engineering, Faculty for Automatic Control and Computers, University Politehnica of Bucharest, 060042 Bucharest, Romania.

ORCID-Profile: Constantin Munteanu, Aurelian Anghelescu, Andreea-Iulia Vlădulescu-Trandafir, Gelu Onose

Förderung

  • "Publication of this paper was supported by the University of Medicine and Pharmacy "Carol Davila" through the institutional program Publish not Perish"
  • “Publication of this paper was supported by the University of Medicine and Pharmacy “Carol Davila” through the institutional program Publish not Perish”

Zitieren

APA

Popescu, C., Munteanu, C., Anghelescu, A., Ciobanu, V., Spînu, A., Andone, I., Mandu, M., Bistriceanu, R., Băilă, M., Postoiu, R. L., Vlădulescu-Trandafir, A. I., Giuvara, S., Malaelea, A. D., & Onose, G. (2024). Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement. International Journal of Molecular Sciences, 25(20), 11272. https://doi.org/10.3390/ijms252011272

Vancouver

Popescu C, Munteanu C, Anghelescu A, Ciobanu V, Spînu A, Andone I, et al. Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement. International Journal of Molecular Sciences. 2024;25(20):11272. doi:10.3390/ijms252011272

BibTeX
@article{Popescu2024,
  author = {Popescu, Cristina and Munteanu, Constantin and Anghelescu, Aurelian and Ciobanu, Vlad and Spînu, Aura and Andone, Ioana and Mandu, Mihaela and Bistriceanu, Roxana and Băilă, Mihai and Postoiu, Ruxandra-Luciana and Vlădulescu-Trandafir, Andreea-Iulia and Giuvara, Sebastian and Malaelea, Alin-Daniel and Onose, Gelu},
  title = {Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {20},
  pages = {11272},
  doi = {10.3390/ijms252011272}
}
Kostenlos starten →